Ihc - OmicsDI

Show results for

Unknown (8411)
Genomics (450)
Transcriptomics (378)
Proteomics (114)
Clinical (21)
Genomic (7)
Other (7)
Metabolomics (7)
Methylation profiling (6)
Multiomics (6)
Models (1)

Organisms

Homo sapiens (351)
Mus musculus (91)
Bombyx mori (61)
Onchocerca volvulus (61)
Klebsiella pneumoniae (61)
Musca domestica (61)
Brugia malayi (61)
Schizosaccharomyces pombe (61)
Streptomyces coelicolor A3(2) (61)
Sus scrofa (61)
Human immunodeficiency virus 1 (61)
Oryza sativa Indica Group (61)
Caenorhabditis elegans (18)
Rattus norvegicus (4)
Drosophila melanogaster (3)
Canis lupus familiaris (3)
Saccharomyces cerevisiae (2)
Arabidopsis thaliana (2)
Macaca mulatta (2)
Sterkiella histriomuscorum (1)
Oxytricha trifallax (1)
Drosophila sechellia (1)
Bifidobacterium breve UCC2003 (1)
synthetic construct (1)
Xenopus laevis (1)
Vibrio cholerae (1)
Acinetobacter baumannii (1)
Solea senegalensis (1)
Homo (1)
Fusarium sinicum (1)

Organisms

Homo sapiens (253)
Mus musculus (68)
Rattus norvegicus (5)
Canis lupus familiaris (2)
Solea senegalensis (1)
fermentation metagenome (1)
Macaca mulatta (1)

Repository

ENA (402)
geo (246)
biostudies-arrayexpress (170)
pride (61)
iProX (31)
EGA (26)
MassIVE (8)
dbGaP (7)
MetaboLights (6)
PanoramaPublic (5)
jPOST (3)
PeptideAtlas (3)
BioModels (1)
GNPS (1)

Tissue

Brain (12)
Cell culture (9)
Epithelial cell (8)
Kidney (4)
Others (3)
Breast (3)
Liver (3)
Colon (3)
Blood plasma (2)
Lung (2)
Internal female genital organ (1)
Cochlear inner hair cell (1)
Oropharyngeal cancer cell (1)
Kidney field (1)
Endometrial cancer cell line (1)
Neurohypophysis (1)
Neck (1)
Central nervous system neuron (1)
Femoral muscle (1)
Synovium (1)
Blood vessel endothelial cell (1)
Corpus luteum (1)
Ovary cancer cell (1)
Myometrium (1)
Culture fluid (1)
Tonsil (1)
Tongue (1)
Head (1)
Inner ear (1)
Amyloid plaque (1)

Disease

Colorectal Neoplasms (7)
Breast cancer (6)
Colorectal cancer (3)
Colon cancer (3)
Endometrial cancer (2)
Alzheimer's disease (2)
Malignant neoplasm of ovary (2)
Disease free (2)
Non-small cell lung carcinoma (1)
Myelolipoma (1)
Mesothelioma (1)
Gastric, gastroesophageal junction and colorectal cancers (1)
Metastatic colorectal cancer refractory to irinotecan treatment (1)
Patients older than 18 years with clinical suspicion of CMV colitis were enrolled. The criteria for clinically suspicious of CMV colitis included: i) presence of at least one of the risk factors, including human immunodeficiency virus infection, solid organ or hematologic stem cell transplantations, hematologic malignancy, inflammatory bowel disease, taking immunosuppressive agents or chemotherapy, and critically ill with multiple comorbidities, and ii) presenting with gastrointestinal tract symptoms, including abdominal pain, gastrointestinal bleeding, diarrhea, and bowel ileus (1)
HNPCC related tumor (1)
Colorectal Neoplasms, Hereditary Nonpolyposis (1)
Colorectal neoplasms malignant (1)
Rectal Cancer (1)
Colonic Neoplasms (1)
Colorectal cancer (1)
Adenoma (1)
Endometrioid ovary carcinoma (1)
Limb ischemia (1)
Rhabdoid cancer (1)
Oral cavity cancer (1)
Ovarian cancer (1)
Oral squamous cell carcinoma (1)
Head and neck cancer (1)
Desmoplastic small round cell tumor (1)
Diabetic retinopathy (1)

Technology Type

Mass Spectrometry (61)
Shotgun proteomics (31)
Bottom-up proteomics (15)
Data-dependent acquisition (9)
Data-independent acquisition (7)
Gel-based experiment (5)
Mass spectrometry (4)
SWATH MS (4)
Mass spectrometry assay (2)
Mass spectrometry imaging (2)
Top-down proteomics (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Illumina HiSeq 2500, Illumina HiSeq 2000 (1)
DiaPASEF (1)
SRM/MRM (1)

Instrument Platform

Q Exactive (3)
MS:1000031 (3)
Liquid Chromatography MS - positive - reverse-phase (2)
Liquid Chromatography MS - negative - reverse-phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (2)
LTQ Orbitrap Elite (2)
Dr. Tom Multi-omics Data Mining System (1)
Animal Experiment Facility (1)
SPF Animal Room (1)
PCR Thermocycler, Fragment Analyzer (1)
Centrifuge, Nucleic Acid Quantification Instrument (1)
Biosafety Cabinet, Liquid Nitrogen Tank, -80°C Freezer (1)
Illumina Genome Analyzer IIx (1)
DNBSEQ-T7 (1)
NextSeq 550 (1)
NextSeq 500 (1)
LTQ Velos (1)
TripleTOF 6600 (1)
TimsTOF (1)
Orbitrap Fusion (1)
Q Exactive HF (1)
Q Exactive Plus (1)
Q Exactive HF-X (1)
Liquid Chromatography MS - (1)
MS Imaging - (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - alternating - reverse phase (1)
QExactive (1)

Publication Date

2025 (56)
2024 (44)
2023 (39)
2015 (36)
2012 (36)
2022 (33)
2021 (30)
2016 (29)
2011 (29)
2010 (29)
2026 (27)
2013 (26)
2020 (22)
2019 (21)
2014 (19)
2009 (13)
2018 (12)
2008 (10)
2017 (6)
2007 (4)
2006 (1)

UNIPROT ID/AC

Q6ZVE7 (3)
Q99619 (3)
Q8N4U5 (3)
Q9UBZ4 (3)
Q96QP1 (3)
Q9Y576 (3)
Q6ZTQ3 (3)
Q9H633 (3)
Q96PC5-2 (3)
Q96PC5 (3)
Q8TDW5 (3)
Q9NXZ2 (3)
Q8IZP6 (3)
Q9UHA2 (3)
Q6MZQ0 (3)
Q9C019 (3)
Q96EP1 (3)
Q8IYM2 (3)
Q86SJ2 (3)
Q02833 (3)
Q9UK32 (1)
Q9H665 (1)
O00443 (1)
Q504U8 (1)
P31751 (1)
P27361 (1)
P04049 (1)
Q02750 (1)
P62070 (1)
Q07889 (1)

ENSEMBL ID

ENSG00000247315 (3)
ENSG00000147251 (3)
ENSG00000170477 (3)

CHEBI ID

CHEBI:192720 (1)
CHEBI:176081 (1)
CHEBI:174500 (1)
CHEBI:26333 (1)
CHEBI:192727 (1)
CHEBI:192724 (1)
CHEBI:192722 (1)
CHEBI:24521 (1)
CHEBI:192719 (1)
CHEBI:132481 (1)
CHEBI:84755 (1)
CHEBI:133179 (1)
CHEBI:170123 (1)
CHEBI:168247 (1)
CHEBI:76318 (1)
CHEBI:81353 (1)
CHEBI:89748 (1)
CHEBI:27376 (1)
CHEBI:171782 (1)
CHEBI:89746 (1)
CHEBI:171691 (1)
CHEBI:165235 (1)
CHEBI:170064 (1)
CHEBI:88543 (1)
CHEBI:135063 (1)
CHEBI:172509 (1)
CHEBI:25305 (1)
CHEBI:30833 (1)
CHEBI:45758 (1)
CHEBI:131886 (1)

Metabolite Name

Metab_21 (1)
ME0117874 (1)
ME0131010 (1)
ME0128050 (1)
ME0014756 (1)
ME0115402 (1)
ME0128038 (1)
ME0162447 (1)
ZINC95912369 (1)
ME0166726 (1)
ME0148637 (1)
ME0153234 (1)
ZINC38256655 (1)
ME0142756 (1)
ME0163862 (1)
FDATN01122 (1)
ME0143548 (1)
ME0163301 (1)
ME0159371 (1)
ME0161995 (1)
ME0168294 (1)
ME0155248 (1)
ME0144105 (1)
ZINC85911136 (1)
ME0161855 (1)
ME0116271 (1)
ZINC13340428 (1)
ME0156087 (1)
ZINC85493085 (1)
ME0166217 (1)

First Public Date

2025 (61)
2024 (57)
2014 (55)
2023 (47)
2021 (35)
2026 (33)
2022 (31)
2020 (20)
2019 (18)
2018 (15)
2015 (14)
2017 (8)
2016 (7)
2013 (1)

Modelling Approach

Ordinary differential equation model (1)

Study status

Completed (9)
Recruiting (5)
Not provided (4)
Ongoing (1)
Active, not recruiting (1)
Not yet recruiting (1)

Lab affiliation

Baylor College of Medicine (2)
associate professor of neurology Institute for cell engineering Johns hopkins university school of medicine (1)
Univ.Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000 Lille, France (1)
Monash University Molecular Biology and Biochemistry (1)
Necker Proteomics, Université Paris Cité - Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR3633, Paris, France. (1)
Stress- and Immunoproteomics Group, Molecular and Applied Microbiology Department, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena (1)
PI, Lab head, Professor, BSBE (1)
Translational gastroenterology, GIGA institute, University of Liege ULiege Belgium and Hepatogastro entreology and digestive oncology University hospitalof Liège, CHU Liège (1)
Guangzhou Women and Children’s Medical Center (1)
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First ST SW, Rochester, MN 55905, USA (1)
Department of Biochemistry, Siebens Drake Research Institute, Western University (1)
PD Dr. Oliver Schilling Heisenberg Fellow Institute of Molecular Medicine and Cell Research University of Freiburg Stefan-Meier-Str. 17, Room 02 027 D-79104 Freiburg, Germany +49 761 203 9615 oliver.schilling@mol-med.uni-freiburg.de (1)
Department of Neurosciences, Lerner Research Institute, Cleveland Clinic (1)
The University of Sydney, Department of Medicine & Health, Kolling Institute (1)
Department of Orthopaedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China (1)
Department of Endocrinology PGIMER, Chandigarh India Dr. Akhilesh Pandey Department of Laboratory Medicine and Pathology Mayo Clinic Rochester, MN (1)
Professor, Deputy Head of Centre Novo Nordisk Foundation Center for Protein Research University of Copenhagen DENMARK (1)
Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain (1)
Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian, Liaoning 116000, P.R. China (1)
Ph.D Research Scholar, Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai-600056 (1)
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznań, Poland (1)
Proteomics Program Novo Nordisk Foundation CPR University of Copenhagen Copenhagen Denmark (1)
ProCan®, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia (1)
Professor, Head of Cancer Research, University of Southern Denmark (1)
Department of Clinical Sciences, Cornell University, 930 Campus Rd, Ithaca, NY, 14853, USA (1)
Section Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (1)
Professor and Deputy Director, Centre for Systems Biology and Molecular Medicine, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore 575018, India (1)
Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain. (1)
Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, E-28220 Madrid, Spain. (1)
Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory and Karolinska Institutet, Stockholm, Sweden (1)

Keyword

Temozolomide (3)
MGMT (2)
Microsatellite stable (2)
Irinotecan (2)
Leucovorin (2)
Bevacizumab (2)
Temozolomide (1)
TEMIRI (1)
Post-adjuvant (1)
Aspirina (1)
METFORAL 850 mg compresse rivestite con film (1)
Mismatch repair (1)
Next-generation sequencing (1)
Intestinal microbiome (1)
Postoperative complications (1)
Microsatellite instability (1)
Stage II (1)
Stage III (1)
Invasion (1)
IHC (1)
First-line (1)
Immunohistochemistry (1)
KEYTRUDA (pembrolizumab, MK-3475) (1)
DNA Mismatch Repair (1)
Mechanical bowel preparation (1)
Metformin (1)
Erbitux (1)
Phase 1 (1)
Anastomotic leakage (1)
EGFR (1)

IsPrivate

False (1)

Study type

Transcription profiling by array (109)
ChIP-chip by tiling array (19)
RNA-seq of coding RNA (16)
Observational (11)
Comparative genomic hybridization by array (10)
Interventional (10)
Methylation profiling by array (4)
RNA-seq of non coding RNA (3)
Proteomic profiling by array (2)
Animal - One-color microarray (1)
Human - Methylation microarray (1)
RNAi profiling by array (1)
Other (1)
ChIP-seq (1)
Genotyping by high throughput sequencing (1)
RNA-seq of total RNA (1)

Release Date

2022 (1203)
2025 (1111)
2023 (1068)
2021 (1002)
2024 (889)
2020 (720)
2019 (542)
2018 (387)
2016 (342)
2017 (330)
2015 (237)
2014 (195)
2013 (125)
2026 (107)
2012 (105)
2011 (70)
2010 (66)
2009 (33)
2008 (20)
2007 (12)
2006 (7)
2005 (3)
2003 (3)
1999 (2)
2002 (1)

Location

Italy (8)
Japan (5)
China (3)
Austria (2)
Slovenia (1)
Thailand (1)
Taiwan (1)
New Zealand (1)
North America (1)
Sweden (1)
France (1)

Previous page
1 / 941
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 941
Next page

Sort by:

Relevance

Page size

Preanalytical impacts on protein stability by IHC evaluation

PRJNA701506 | ENA

Integrative Assessment of RNA-seq and IHC: Linking Tumor Biomarkers and Microenvironment

PRJNA1245330 | ENA

Integrative Assessment of RNA-seq and IHC: Linking Tumor Biomarkers and Microenvironment

This study aimed to assess the correlation between RNA sequencing (RNA-seq) and immunohistochemistry (IHC) in detecting key cancer biomarkers across solid tumors, and then, to establish RNA-seq thresholds that accurately reflect clinical IHC classifications. Expression levels of nine biomarkers—ESR1...

ORGANISM(S): Homo sapiens

2025-08-06 | GSE293591 | GEO

Fallopian tube lesions as potential precursors of early ovarian cancer: A comprehensive proteomic analysis.

The main goal of this study is to explore the proteomic expression in prophylactic salpingooophorectomy specimens, obtained from highly selected cohort of patients at risk of developing a high-grade serous ovarian carcinoma (HGSOC), because of a hereditary (BRCA 1 or 2 mutation) or a documented fami...

ORGANISM(S): Homo sapiens (Human)

2023-10-24 | PXD020024 | Pride

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

The neuroendocrine (NE) phenotype is associated with the development of metastatic castration-resistant prostate cancer (CRPC). Our objective was to characterize the molecular features of the NE phenotype in CRPC. Expression of chromogranin A (CHGA), synaptophysin (SYP), androgen receptor (AR), and ...

ORGANISM(S): Homo sapiens

2015-06-24 | E-GEOD-66187 | biostudies-arrayexpress

MALDI-IHC-Guided In-Depth Spatial Proteomics: Targeted and Untargeted MSI Combined.

Not available

S-EPMC9893213 | biostudies-literature

Automated multi-regional IHC scoring enhances prognostication in colorectal cancer.

Not available

S-EPMC12445426 | biostudies-literature

The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control.

Not available

S-EPMC5533270 | biostudies-literature

MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas.